$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and st 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-021/00
출원번호 US-0478741 (1990-02-12)
우선권정보 JP-0211157 (1986-09-08); JP-0013726 (1987-01-23)
발명자 / 주소
  • Ohtsuka Eiko (Sappro JPX) Inoue Hideo (Sappro JPX) Morisawa Hirokazu (Kawasaki JPX) Shibahara Susumu (Kawasaki JPX) Mukai Sachiko (Kawasaki JPX) Nishihara Tohru (Kurashiki JPX)
출원인 / 주소
  • Ajinomoto Co., Inc. (Tokyo JPX 03)
인용정보 피인용 횟수 : 242  인용 특허 : 5

초록

There is disclosed a compound having a double chain which is composed of an RNA (+chain) and a complementary DNA (-chain), wherein a portion of the DNA (-chain) has been replaced by an RNA or a derivative thereof, and wherein, when the compound is subjected to the action of an enzyme having a ribonu

대표청구항

A compound having a double chain and which is composed of an RNA (+chain) and a complementary DNA (-chain), wherein at least one portion of said DNA (-chain) has been replaced by a 2′-O-substituted RNA, wherein said 2′-O-substituted RNA has at least one substituted 2′-hydroxyl group on the ribose mo

이 특허에 인용된 특허 (5)

  1. Kempe Tomas (Minnetonka MN) Purchio Anthony F. (Edina MN) Collett Marc S. (Minnetonka MN) DeLorbe William J. (Minnetonka MN), Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides.
  2. Caruthers Marvin H. (Boulder CO) Beaucage Serge L. (Boulder CO), Phosphoramidite compounds and processes.
  3. Kster Hubert (Hamburg DEX) Sinha Nanda D. (Bundu Dt. Ranchi INX), Process for the preparation of oligonucleotides.
  4. Paddock Gary V. (Mount Pleasant SC), Recombinant cDNA construction method and hybrid nucleotides useful in cloning.
  5. Itakura Keiichi (Arcadia CA), Solid-phase synthesis of polynucleotides.

이 특허를 인용한 특허 (242)

  1. Buhr Chris A. ; Matteucci Mark, 2' Modified Oligonucleotides.
  2. Chris A. Buhr ; Mark Matteucci, 2' Modified oligonucleotides.
  3. Cook Phillip Dan ; Manoharan Muthiah ; Kawasaki Andrew Mamoru, 2'-O-aminooxy-modified oligonucleotides.
  4. Cook Phillip Dan ; Guinosso Charles John, 2'-O-modified nucleosides and phosphoramidites.
  5. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-O-modified oligonucleotides.
  6. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  7. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  8. Cook, Phillip Dan; Kawasaki, Andrew Mamoru, 2'modified oligonucleotides.
  9. Buhr, Chris A.; Matteucci, Mark, 2′ Modified oligonucleotides.
  10. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  11. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5'-modified bicyclic nucleic acid analogs.
  12. Swayze, Eric E.; Prakash, Thazha P., 5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom.
  13. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  14. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  15. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  16. Seth, Punit P.; Swayze, Eric E., 6-disubstituted or unsaturated bicyclic nucleic acid analogs.
  17. Seth, Punit P.; Swayze, Eric E., 6-modified bicyclic nucleic acid analogs.
  18. Seth, Punit P.; Swayze, Eric E., 6-modified bicyclic nucleic acid analogs.
  19. Seth,Punit P.; Swayze,Eric E., 6-modified bicyclic nucleic acid analogs.
  20. Manoharan, Muthiah; Lonnberg, Harri; Salo, Harri; Virta, Pasi, Aminooxy functionalized oligomers.
  21. Manoharan, Muthiah; Lonnberg, Harri; Salo, Harri; Virta, Pasi, Aminooxy functionalized oligomers, oligomer arrays and methods of using them.
  22. Cook Phillip Dan ; Manoharan Muthiah ; Kawasaki Andrew Mamoru, Aminooxy-modified oligonucleotide synthetic intermediates.
  23. Manoharan Muthiah ; Cook Phillip Dan ; Prakash Thazha P. ; Kawasaki Andrew M., Aminooxy-modified oligonucleotides and methods for making same.
  24. Colton, Clark K.; Watterson, Arthur; Kumar, Rajesh; Parmar, Virinder S.; Fisher, Robert; Kumar, Jayant, Amphiphilic polymers and methods of use thereof.
  25. Cairns, Belinda; Chen, Ruihuan; Frantz, Gretchen; Hillan, Kenneth J.; Koeppen, Hartmut; Phillips, Heidi S.; Polakis, Paul; Spencer, Susan D.; Smith, Victoria; Williams, P. Mickey; Wu, Thomas D.; Zhang, Zemin, Anti-TAT188 antibodies.
  26. Cairns, Belinda; Chen, Ruihuan; Frantz, Gretchen; Hillan, Kenneth J.; Koeppen, Hartmut; Phillips, Heidi S.; Polakis, Paul; Spencer, Susan D.; Smith, Victoria; Williams, P. Mickey; Wu, Thomas D.; Zhang, Zemin; Sakanaka, Chie; Chuntharapai, Anan; Reed, Chae Janeka, Antibody compositions for the diagnosis and treatment of tumor.
  27. Iversen, Patrick L., Antisense antiviral compound and method for treating influenza viral infection.
  28. Iversen, Patrick L., Antisense antiviral compound and method for treating influenza viral infection.
  29. Miraglia Loren ; Bennett C. Frank ; Dean Nicholas ; Geiger Thomas,DEX, Antisense compositions and methods for modulating type I interleukin-1 receptor expression.
  30. Armstrong, Dustin D., Antisense conjugates for decreasing expression of DMPK.
  31. Armstrong, Dustin D., Antisense conjugates for decreasing expression of DMPK.
  32. David J. Ecker ; Phillip Dan Cook ; Brett P. Monia ; Susan M. Freier ; Yogesh S. Sanghvi, Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
  33. Ecker David J. ; Cook Phillip Dan ; Monia Brett P. ; Freier Susan M. ; Sanghvi Yogesh S., Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
  34. Bennett, C. Frank; Cowsert, Lex M.; Siwkowski, Andrew M., Antisense modulation of CD40 expression.
  35. Smolke, Christina D.; Bayer, Travis S., Aptamer regulated nucleic acids and uses thereof.
  36. Smolke, Christina D.; Bayer, Travis S., Aptamer regulated nucleic acids and uses thereof.
  37. Smolke, Christina D.; Bayer, Travis S., Aptamer regulated nucleic acids and uses thereof.
  38. Shah, Shishir, Arrays, computer program products and methods for in silico array-based comparative binding assays.
  39. Allerson, Charles; Bhat, Balkrishen; Swayze, Eric E., Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom.
  40. Seth, Punit P.; Swayze, Eric E., Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom.
  41. Seth, Punit P.; Migawa, Michael T.; Swayze, Eric E.; Song, Quanlai; Han, Mingming; Ross, Bruce S., Bicyclic cyclohexitol nucleic acid analogs.
  42. Migawa, Michael T.; Seth, Punit P.; Swayze, Eric E.; Ross, Bruce S.; Song, Quanlai; Han, Mingming, Bicyclic cyclohexose nucleic acid analogs.
  43. Seth, Punit P.; Swayze, Eric E., Bicyclic morpholino compounds and oligomeric compounds prepared therefrom.
  44. Seth, Punit P.; Swayze, Eric E.; Hanessian, Stephen; Schroeder, Benjamin R., Bicyclic nucleosides and oligomeric compounds prepared therefrom.
  45. Seth, Punit P.; Swayze, Eric E., Bis-modified bicyclic nucleic acid analogs.
  46. Seth, Punit P.; Swayze, Eric E., Bis-modified bicyclic nucleic acid analogs.
  47. Seth, Punit P.; Swayze, Eric E., Carbocyclic alpha-L-bicyclic nucleic acid analogs.
  48. Seth, Punit P.; Swayze, Eric E., Carbocyclic bicyclic nucleic acid analogs.
  49. Kmiec Eric B., Chimeric mutational vectors having non-natural nucleotides.
  50. Kmiec Eric B., Chimeric mutational vectors having non-natural nucleotides.
  51. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  52. Bennett, Clarence Frank; Ecker, David J.; Cook, Phillip Dan, Composition and methods for the pulmonary delivery of nucleic acids.
  53. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Compositions and methods for modulating HBV expression.
  54. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  55. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  56. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  57. Migawa, Michael T.; Lima, Walter F.; Swayze, Eric E.; Nichols, Joshua; Wu, Hongjiang; Prakash, Thazha P.; Wyrzykiewicz, Tadeusz Krzysztof; Bhat, Balkrishen; Crooke, Stanley T., Compositions and methods for optimizing cleavage of RNA by RNase H.
  58. Mehta, Rahul C.; Hardee, Gregory E.; Cook, Phillip Dan; Ecker, David J.; Tsai, Yali Jennifer; Templin, Michael V., Compositions and methods for topical delivery of oligonucleotides.
  59. Kirkland, III, Theo N.; Viriyakosol, Sunganya, Compositions and methods using MD-2 mutants and chimeric proteins.
  60. Dobie, Kenneth W.; Dean, Nicholas M.; Bennett, C. Frank, Compositions and their uses directed to HBXIP.
  61. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2'-modified nucleosides for use in gene modulation.
  62. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  63. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  64. Cook Phillip Dan ; Ecker David J. ; Guinosso Charles John ; Acevedo Oscar Leobardo ; Kawasaki Andrew ; Ramasamy Kandasamy, Compound for detecting and modulating RNA activity and gene expression.
  65. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression ApoB.
  66. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of DGAT2.
  67. Bhanot, Sanjay; Geary, Richard; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCCR.
  68. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCGR.
  69. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of SGLT2.
  70. Bennett, C. Frank, Compounds and methods for modulating protein expression.
  71. Bennett, C. Frank, Compounds and methods for modulating protein expression.
  72. Kmiec Eric B., Compounds and methods for site directed mutations in eukaryotic cells.
  73. Bhat, Balkrishen; Xia, Jie; Seth, Punit P.; Vasquez, Guillermo; Migawa, Michael T.; Allerson, Charles; Prakash, Thazha P.; Swayze, Eric E., Compounds and methods for synthesis of bicyclic nucleic acid analogs.
  74. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  75. Peled, Tony; Steinhardt, Yair, Culturing of mesenchymal stem cells with FGF4 and nicotinamide.
  76. Seth, Punit P.; Swayze, Eric E., Cyclohexenyl nucleic acids analogs.
  77. Seth, Punit P.; Swayze, Eric E., Cyclohexenyl nucleic acids analogs.
  78. K?ster,Hubert; Braun,Andreas; van den Boom,Dirk; Jurinke,Christian; Ruppert,Andreas; Hillenkamp,Franz; Little,Daniel P., DNA diagnostics based on mass spectrometry.
  79. K��ster,Hubert; Braun,Andreas; van den Boom,Dirk; Jurinke,Christian; Ruppert,Andreas; Hillenkamp,Franz, DNA diagnostics based on mass spectrometry.
  80. Walder Joseph A. ; Walder Roxanne Y. ; Eder Paul S. ; Dagle John M., DNA molecules stabilized by modifications of the 3'-terminal phosphodiester linkage.
  81. Feng, Lang; Chaikin, Paul Michael, DNA photolithography with cinnamate crosslinkers.
  82. Macevicz Stephen C., DNA sequencing by parallel oligonucleotide extensions.
  83. Mirkin, Chad A.; Paller, Amy S.; Giljohann, David A., Delivery of oligonucleotide functionalized nanoparticles.
  84. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Diagnosis and treatment of disease.
  85. Kraynack, Bryan A.; Baker, Brenda F.; Bhat, Balkrishen; Swayze, Eric E.; Griffey, Richard H., Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation.
  86. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  87. Woolf, Tod, Double-stranded oligonucleotides.
  88. Woolf, Tod; Wiederholt, Kristin, Double-stranded oligonucleotides.
  89. Woolf, Tod; Wiederholt, Kristin, Double-stranded oligonucleotides.
  90. Brian Froehler ; Rick Wagner ; Mark Mattencci ; Robert J. Jones ; Arnold J. Gutierrez ; Jeff Pudlo, Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  91. Froehler, Brian; Wagner, Rick; Matteucci, Mark; Jones, Robert J.; Gutierrez, Arnold J.; Pudlo, Jeff, Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  92. Froehler, Brian; Wagner, Rick; Matteucci, Mark; Jones, Robert J.; Gutierrez, Arnold J.; Pudlo, Jeff, Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  93. Froehler,Brian; Wagner,Rick; Mattencci,Mark; Jones,Robert J.; Gutierrez,Arnold J.; Pudlo,Jeff, Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  94. Peled, Tony; Frei, Gabi M., Enhancement of natural killer (NK) cell proliferation and activity.
  95. Franch, Thomas; Lundorf, Mikkel Dybro; Jacobsen, Søren Nyboe; Olsen, Eva Kampmann; Andersen, Anne Lee; Holtmann, Anette; Hansen, Anders Holm; Sørensen, Anders Malling; Goldbech, Anne; de Leon, Daen; Kaldor, Ditte Kievsmose; Sløk, Frank Abildgaard; Husemoen, Gitte Nystrup; Dolberg, Johannes; Jensen, Kim Birkebæ; Pedersen, Lene; Nørregaard-Madsen, Mads; Godskesen, Michael Anders; Glad, Sanne Schrøder; Neve, Søren; Thisted, Thomas; Kronborg, Tine Titilola Akinleminu; Sams, Christian Klarner; Felding, Jakob; Freskgård, Per-Ola; Gouliaev, Alex Haahr; Pedersen, Henrik, Enzymatic encoding methods for efficient synthesis of large libraries.
  96. Leeds Janet M. ; Cummins Lendell L., Fluorescence based nuclease assay.
  97. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  98. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  99. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  100. Cook Phillip Dan, Gapped 2'-modified oligonucleotides.
  101. Swayze, Eric E.; Migawa, Michael T.; Wyrzykiewicz, Tadeusz Krzysztof, Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini.
  102. Cook,Phillip Dan; Monia,Brett P., Gapped oligonucleotides.
  103. Kasid,Usha; Gokhale,Prafulla; Kumar,Deepak; Broustas,Constantinos; Ahmad,Imran; Dritschilo,Anatoly; Rahman,Aquilur, Gene BRCC-2 and diagnostic and therapeutic uses thereof.
  104. Kasid,Usha; Gokhale,Prafulla; Kumar,Deepak; Boudreau,Howard; Ahmad,Imran; Dritschilo,Anatoly; Rahman,Aquilur, Gene BRCC-3 and diagnostic and therapeutic uses thereof.
  105. Kasid,Usha; Kumar,Deepak; Ahmad,Imran, Gene SCC-112 and diagnostic and therapeutic uses thereof.
  106. Kasid,Usha; Sakabe,Isamu; Ahmad,Imran, Gene SHINC-2 and diagnostic and therapeutic uses thereof.
  107. Kasid,Usha; Sakabe,Isamu; Ahmad,Imran, Gene shinc-3 and diagnostic and therapeutic uses thereof.
  108. Stephanopoulos, Gregory; Alper, Hal S.; Jin, Yong-Su, Gene targets for enhanced carotenoid production.
  109. Stephanopoulos, Gregory; Alper, Hal S.; Jin, Yong-Su, Gene targets for enhanced carotenoid production.
  110. Smolke, Christina D.; Win, Maung Nyan; Beisel, Chase, General composition framework for ligand-controlled RNA regulatory systems.
  111. Smolke, Christina D.; Chen, Yvonne Y.; Jensen, Michael C., Genetic control of mammalian cells with synthetic RNA regulatory systems.
  112. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  113. Brown, David; Ford, Lance P.; Jarvis, Richard A.; Pallotta, Vince; Pasloske, Brittan L., High potency siRNAS for reducing the expression of target genes.
  114. Smolke, Christina D.; Win, Maung Nyan; Beisel, Chase, Higher-order cellular information processing devices.
  115. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  116. Metelev Valeri,RUX ; Agrawal Sudhir, Hybrid oligonucleotide phosphorothioates.
  117. Metelev, Valeri; Agrawal, Sudhir, Hybrid oligonucleotide phosphorothioates.
  118. Metelev,Valeri; Agrawal,Sudhir, Hybrid oligonucleotide phosphorothioates.
  119. Valeri Metelev RU; Sudhir Agrawal, Hybrid oligonucleotide phosphorothioates.
  120. Smolke, Christina D.; Beisel, Chase L., Integrated—ligand-responsive microRNAs.
  121. Braun,Andreas; Cantor,Charles R.; Kammerer,Stefan M.; Taylor,Susan; Burns Hamuro,Lora; Cook,Charles; Olson,Gary; Self,Christopher, Kinase anchor protein muteins, peptides thereof and related documents.
  122. Manoharan, Muthiah, Ligand-conjugated oligomeric compounds.
  123. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  124. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  125. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  126. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  127. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  128. Pearlman, Andrew; Stern, Baruch S., Long lasting drug formulations.
  129. Köster, Hubert, Mass spectrometric methods for detecting mutations in a target nucleic acid.
  130. K철ster,Hubert, Mass spectrometric methods for detecting mutations in a target nucleic acid.
  131. K��ster,Hubert, Mass spectrometric methods for detecting mutations in a target nucleic acid.
  132. Gleave, Martin E.; Ischia, Joseph, Method for treatment of castration-resistant prostate cancer.
  133. Cedillo, Isaiah E.; Janczak, Darren; Weaver, Phillip Michael, Method of preparing oligomeric compounds using modified capping protocols.
  134. Eberwine, James; Langel, Ulo; Kilk, Kalle; Zielinski, Jennifer, Methods and compositions for identifying RNA-binding proteins.
  135. Walder Joseph A. ; Walder Roxanne Y. ; Eder Paul S. ; Dagle John M., Methods for decreasing the expression of specifically targeted genes.
  136. Braun, Andreas; Koster, Hubert; Van den Boom, Dirk; Yip, Ping; Rodi, Charles; He, Liyan; Chiu, Norman; Jurinke, Christiane, Methods for generating databases and databases for identifying polymorphic genetic markers.
  137. Braun, Andreas; Köster, Hubert; Van Den Boom, Dirk Johannes; Yip, Ping; Rodi, Charles; He, Liyan; Chiu, Norman; Jurinke, Christian, Methods for generating databases and databases for identifying polymorphic genetic markers.
  138. Köster, Hubert; Braun, Andreas; Van Den Boom, Dirk; Ping, Yip; Rodi, Charlie; He, Liyan; Chiu, Norman; Jurinke, Christian, Methods for generating databases and databases for identifying polymorphic genetic markers.
  139. Bennett, C. Frank; Freier, Susan M.; Pulst, Stefan M.; Scoles, Daniel R.; Hung, Gene, Methods for modulating Ataxin 2 expression.
  140. Peled, Tony; Fibach, Eitan; Treves, Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  141. Peled, Tony; Fibach, Eitan; Treves, Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  142. Peled,Tony; Fibach,Eitan; Treves,Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  143. Peled,Tony; Fibach,Eitan; Treves,Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  144. Peled, Tony; Steinhardt, Yair, Methods of culturing and expanding mesenchymal stem cells.
  145. Peled, Tony; Treves, Avi; Rosen, Oren, Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby.
  146. Peled,Tony; Treves,Avi; Rosen,Oren, Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby.
  147. Grasso, Luigi; Liang, Shaohong; Nicolaides, Nicholas C.; Sass, Philip M., Methods of generating high-production of antibodies from hybridomas created by in vitro immunization.
  148. Grasso, Luigi; Liang, Shaohong; Nicolaides, Nicholas C.; Sass, Philip M., Methods of generating high-production of antibodies from hybridomas created by in vitro immunization.
  149. Peled, Tony, Methods of improving stem cell homing and engraftment.
  150. Werner, Christian; Nerenz, Frank; Kanschik-Conradsen, Andreas; Reddy, Kalakota, Methods of producing phosphitylated compounds.
  151. Werner,Christian; Nerenz,Frank; Kanschik Conradsen,Andreas; Reddy,Kalakota S., Methods of producing phosphitylated compounds.
  152. Froehler Brian ; Wagner Rick ; Matteucci Mark ; Jones Robert J. ; Gutierrez Arnold J. ; Pudlo Jeff, Methods of using oligomers containing modified pyrimidines.
  153. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom.
  154. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom.
  155. Galloway, Katie; Smolke, Christina D.; Win, Maung Nyan, Modular aptamer-regulated ribozymes.
  156. Galloway, Katie; Smolke, Christina D.; Win, Maung Nyan, Modular aptamer-regulated ribozymes.
  157. Smolke, Christina D.; Win, Maung Nyan; Beisel, Chase L., Modular polynucleotides for ligand-controlled regulatory systems.
  158. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  159. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  160. Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP2 expression.
  161. Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP2 expression.
  162. Bhanot,Sanjay; Dobie,Kenneth W.; Jain,Ravi, Modulation of eIF4E-BP2 expression.
  163. Brown-Driver, Vickie L.; Jain, Ravi, Modulation of transthyretin expression.
  164. Freier, Susan M., Modulation of transthyretin expression.
  165. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Modulation of transthyretin expression.
  166. Nygren, Anders Olof Herman, Multiplexed method for the identification and quantitation of minor alleles and polymorphisms.
  167. Prakash, Thazha P.; Bhat, Balkrishin; Swayze, Eric E., N-substituted-aminomethylene bridged bicyclic nucleic acid analogs.
  168. Mirkin, Chad A.; Ko, Caroline H.; Stegh, Alexander; Giljohann, David A.; Luciano, Janina; Jensen, Samuel A., Nanoconjugates able to cross the blood-brain barrier.
  169. Wahlestedt, Claes, Natural antisense and non-coding RNA transcripts as drug targets.
  170. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight, Nucleic acid functionalized nanoparticles for therapeutic applications.
  171. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  172. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  173. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nonoparticles for therapeutic applications.
  174. Thompson, James; Beigelman, Leonid; McSwiggen, James; Karpeisky, Alexander; Bellon, Laurent; Reynolds, Mark; Zwick, Michael; Jarvis, Thale; Woolf, Tod; Haeberli, Peter; Matulic-Adamic, Jasenka, Nucleic acid molecules with novel chemical compositions capable of modulating gene expression.
  175. Andrei P. Guzaev ; Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Nucleosidic and non-nucleosidic folate conjugates.
  176. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen; Guzzaev, Andrei P., Nucleosidic and non-nucleosidic folate conjugates.
  177. Esau, Christine; Swayze, Eric E.; Bhat, Balkrishen; Kinberger, Garth A., Oligomeric compounds and compositions for the use in modulation of microRNAs.
  178. Esau, Christine; Swayze, Eric E.; Bhat, Balkrishen; Kinberger, Garth A., Oligomeric compounds and compositions for the use in modulation of micrornas.
  179. Esau, Christine; Swayze, Eric E.; Bhat, Balkrishen; Kinberger, Garth A., Oligomeric compounds and compositions for the use in modulation of target nucleic acids.
  180. Swayze, Eric E.; Bhat, Balkrishen; Lima, Walter F.; Prakash, Thazha P.; Kinberger, Garth A., Oligomeric compounds and methods.
  181. Swayze, Eric E.; Bhat, Balkrishen; Lima, Walter F.; Prakash, Thazha P.; Kinberger, Garth A., Oligomeric compounds and methods.
  182. Bhat, Balkrishen; Dande, Prasad; Prakash, Thazha P.; Allerson, Charles; Swayze, Eric E.; Griffey, Richard H., Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation.
  183. Oestergaard, Michael; Swayze, Eric E.; Seth, Punit P., Oligomeric compounds comprising alpha-beta-constrained nucleic acid.
  184. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucelosides and methods for their use.
  185. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucelosides and methods for their use.
  186. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucleosides and methods for their use.
  187. Seth, Punit P.; Swayze, Eric E., Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside.
  188. Cook Phillip Dan ; Sanghvi Yogesh S. ; Sprankle Kelly G. ; Ross Bruce S. ; Griffey Rich H., Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions.
  189. Sanghvi Yogesh S. ; Cook Phillip Dan, Oligonucleoside linkages containing adjacent nitrogen atoms.
  190. Sanghvi Yogesh S. ; Cook Phillip Dan, Oligonucleoside linkages containing adjacent nitrogen atoms.
  191. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  192. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  193. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  194. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  195. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen, Oligonucleotide-folate conjugates.
  196. Bischofberger Norbert ; Kent Ken ; Wagner Rick ; Buhr Chris ; Lin Kuei-Ying, Oligonucleotides and their analogs capable of passive cell membrane permeation.
  197. Manoharan, Muthiah, Oligonucleotides conjugated to protein-binding drugs.
  198. Cook,Phillip Dan; McGee,Daniel Peter Claude; Guinosso,Charles John, Oligonucleotides containing 2'-O-modified purines.
  199. Manoharan,Muthiah; Mohan,Venkatraman; Cook,Phillip Dan; Kawasaki,Andrew M., Oligonucleotides having A-DNA form and B-DNA form conformational geometry.
  200. Crooke Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  201. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  202. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  203. Crooke,Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  204. Crooke,Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  205. Crooke Stanley T., Oligoribonucleotides for cleaving RNA.
  206. Cook Phillip Dan, PNA-DNA-PNA chimeric macromolecules.
  207. Mirkin, Chad A.; Seferos, Dwight S.; Giljohann, David A., Particles for detecting intracellular targets.
  208. Mirkin, Chad A.; Seferos, Dwight; Giljohann, David A., Particles for detecting intracellular targets.
  209. Braun, Andreas, Polymorphic kinase anchor proteins and nucleic acids encoding the same.
  210. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight S.; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  211. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  212. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  213. Cook Phillip Dan ; Sanghvi Yogesh S. ; Sprankle Kelly G. ; Ross Bruce S. ; Griffey Rich H. ; Springer Robert H., Process for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom.
  214. Cook, Phillip Dan; Sanghvi, Yogesh S.; Sprankle, Kelly G.; Ross, Bruce S.; Griffey, Rich H.; Springer, Robert H., Process for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom.
  215. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Short antisense compounds with gapmer configuration.
  216. Han, Si-Ping; Barish, Robert D.; Goddard, III, William A., Signal activated RNA interference.
  217. Seth, Punit P.; Prakash, Thazha P.; Swayze, Eric E., Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom.
  218. Prakash, Thazha P.; Swayze, Eric E., Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom.
  219. Seth, Punit P.; Swayze, Eric E., Substituted alpha-L-bicyclic nucleosides.
  220. Cook,Phillip Dan; Kawasaki,Andrew Mamoru, Sugar modified oligonucleotides.
  221. Phillip Dan Cook, Sugar modified oligonucleotides.
  222. Cook Philip Dan ; Kawasaki Andrew M., Sugar modified oligonucleotides that detect and modulate gene expression.
  223. Pierre Martin CH; Karl-Heinz Altmann CH; Phillip Dan Cook ; Brett P. Monia, Sugar-modified gapped oligonucleotides.
  224. Muesing, Mark A.; Cunningham, Tshaka J., Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof.
  225. Segev, David, System for delivering therapeutic agents into living cells and cells nuclei.
  226. Segev, David, System for delivering therapeutic agents into living cells and cells nuclei.
  227. Segev, David, System for delivering therapeutic agents into living cells and cells nuclei.
  228. Segev, David, System for delivering therapeutic agents into living cells and cells nuclei.
  229. Segev, David, System for delivering therapeutic agents into living cells and cells nuclei.
  230. Cowsert,Lex M.; Baker,Brenda F.; McNeil,John; Freier,Susan M.; Sasmor,Henri M.; Brooks,Douglas G.; Ohashi,Cara; Wyatt,Jacqueline R.; Borchers,Alexander H.; Vickers,Timothy A., System of components for preparing oligonucleotides.
  231. Pedersen, Henrik; Gouliaev, Alex Haahr; Franch, Thomas; Sams, Christian Klarner; Olsen, Eva Kampmann; Slok, Frank Abilgaard; Husemoen, Gitte Nystrup; Felding, Jakob; Hyldtoft, Lene; Norregaard-Madsen, Mads; Godskesen, Michael Anders; Glad, Sanne Schroder; Thisted, Thomas; Freskgard, Per-Ola; Holtmann, Anette, Templated molecules and methods for using such molecules.
  232. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  233. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  234. Prakash, Thazha P.; Swayze, Eric E., Tetrahydropyran nucleic acid analogs.
  235. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  236. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  237. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  238. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  239. Arrow, Amy; Dale, Roderic M. K.; Woolf, Tod Mitchell, Three component chimeric antisense oligonucleotides.
  240. Faghihi, Mohammad Ali; Coito, Carlos, Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF.
  241. Hanash, Samir M.; Rickman, David; Tyagi, Rachana; Zhu, Xiao-Xiang; Kish, Phillip, Treatments and markers for cancers of the central nervous system.
  242. Seth, Punit P.; Swayze, Eric E.; Hanessian, Stephen; Schroeder, Benjamin R.; Giacometti, Robert D.; Merner, Bradley L., Tricyclic nucleic acid analogs.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로